Literature DB >> 15084255

The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons.

Christelle Sabatier1, Andrew S Plump, Katja Brose, Atsushi Tamada, Fujio Murakami, Eva Y-H P Lee, Marc Tessier-Lavigne.   

Abstract

Commissural axons in vertebrates and insects are initially attracted to the nervous system midline, but once they reach this intermediate target they undergo a dramatic switch, becoming responsive to repellent Slit proteins at the midline, which expel them onto the next leg of their trajectory. We have unexpectedly implicated a divergent member of the Robo family, Rig-1 (or Robo3), in preventing premature Slit sensitivity in mammals. Expression of Rig-1 protein by commissural axons is inversely correlated with Slit sensitivity. Removal of Rig-1 results in a total failure of commissural axons to cross. Genetic and in vitro analyses indicate that Rig-1 functions to repress Slit responsiveness similarly to Commissureless (Comm) in Drosophila. Unlike Comm, however, Rig-1 does not produce its effect by downregulating Robo receptors on precrossing commissural axon membranes. These results identify a mechanism for regulating Slit repulsion that helps choreograph the precise switch from attraction to repulsion at a key intermediate axonal target.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084255     DOI: 10.1016/s0092-8674(04)00303-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  157 in total

1.  Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling.

Authors:  Alexander Jaworski; Marc Tessier-Lavigne
Journal:  Nat Neurosci       Date:  2012-02-05       Impact factor: 24.884

2.  Slits affect the timely migration of neural crest cells via Robo receptor.

Authors:  Dion Giovannone; Michelle Reyes; Rachel Reyes; Lisa Correa; Darwin Martinez; Hannah Ra; Gustavo Gomez; Joshua Kaiser; Le Ma; Mary-Pat Stein; Maria Elena de Bellard
Journal:  Dev Dyn       Date:  2012-06-23       Impact factor: 3.780

Review 3.  Navigating intermediate targets: the nervous system midline.

Authors:  Barry J Dickson; Yimin Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 4.  Cellular strategies of axonal pathfinding.

Authors:  Jonathan Raper; Carol Mason
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

Review 5.  Mechanisms and molecules of neuronal wiring: a primer.

Authors:  Alex L Kolodkin; Marc Tessier-Lavigne
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

6.  BARHL2 transcription factor regulates the ipsilateral/contralateral subtype divergence in postmitotic dI1 neurons of the developing spinal cord.

Authors:  Qian Ding; Pushkar S Joshi; Zheng-Hua Xie; Mengqing Xiang; Lin Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

7.  The Intracellular Domain of the Frazzled/DCC Receptor Is a Transcription Factor Required for Commissural Axon Guidance.

Authors:  Alexandra Neuhaus-Follini; Greg J Bashaw
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

8.  The homeodomain transcription factor Hb9 controls axon guidance in Drosophila through the regulation of Robo receptors.

Authors:  Celine Santiago; Juan-Pablo Labrador; Greg J Bashaw
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

9.  Slit molecules prevent entrance of trunk neural crest cells in developing gut.

Authors:  Nora Zuhdi; Blanca Ortega; Dion Giovannone; Hannah Ra; Michelle Reyes; Viviana Asención; Ian McNicoll; Le Ma; Maria Elena de Bellard
Journal:  Int J Dev Neurosci       Date:  2014-12-06       Impact factor: 2.457

10.  Sim1a and Arnt2 contribute to hypothalamo-spinal axon guidance by regulating Robo2 activity via a Robo3-dependent mechanism.

Authors:  Jörn Schweitzer; Heiko Löhr; Joshua L Bonkowsky; Katrin Hübscher; Wolfgang Driever
Journal:  Development       Date:  2013-01-01       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.